The first plenary session of the EU Parliament in the second semester of 2018 was held on 11 September, where the main challenges and topics of the next six month have been outlined.

Hungarian hospitals are facing problems paying for drugs and medical devices. Many suppliers have claims worth millions of euros and are having difficulty enforcing them against either the hospitals or the Hungarian government.

The OGYÉI modified the system of professional consultation as of June 1 2017.

The first quarter of 2009 saw considerable change in the regulation on the promotion of medicines.

Significant legal changes occurred in the Hungarian pharmaceutical and food industry in the summer of 2023. According to Government Decree No. 333/2023.

Most of us have likely encountered a situation where we bought our favourite chocolate at the grocery store...

In response to escalating inflation, the Hungarian government has introduced a new decree effective from March 17 to May 31, 2025...

On 27 June 2011 the Hungarian Parliament adopted a bill amending, "inter alia", the Medicinal Thrift Act (Act No. XCVIII of 2006).

Last year, the Hungarian Competition Authority ("GVH") commenced a series of consultations to identify the markets most impacted by competition law violations and to raise awareness among businesses of its significance.

The Hungarian Competition Authority ("GVH") in the last couple of months has taken regulatory measures in various product markets explored in our latest articles regarding its HoReCa sector inquiry...

The Hungarian Competition Authority (HCA) has found that since October 2023, the Hungarian Energy Drinks Association (EDA) has been using advertising on its website and television programs that is potentially.

As of November 20, 2017, the National Institute for Pharmacy and Nutrition (Hungarian acronym: "OGYEI") has amended the notification of food supplements, baby formulas and special medical purpose nutrition supplements.

June 2026 – In case Kfv.VI.37.810/2025/27, the Hungarian Supreme Court (the “Supreme Court”) reviewed an administrative dispute concerning the marketing authorisation of a generic medicinal product.

Európai kooperációs partnereinkkel közösen jogi képviseletet és jogi tanácsadást vállalunk európai és magyar élelmiszeripari termék és előállítás engedélyezési ügyekkel, élelmiszerbiztonsági hivatali intézkedésekkel...

According to Hungarian law, protection for pharmaceutical patents may – generally speaking - be granted in 3 different ways:

The Decree sets forth the obligations of pharmaceutical waste collection, management and disposal of pharmaceutical waste...

Pharmaceutical companies and other healthcare suppliers have always been of special interest to the Hungarian Competition Authority (HCA) due to the associated public health concerns.

The European Food Safety Authority (EFSA) has introduced significant updates to its Novel Food Guidance, which took effect in February 2025.

Az Európai Élelmiszerbiztonsági Hatóság (EFSA) jelentős frissítéseket vezetett be a Novel-Food irányelveiben, amelyek 2025 februárjában léptek hatályba.